Litigation Details for Pfizer Inc. v. Micro Labs USA Inc. (D. Del. 2017)

Pfizer Inc. v. Micro Labs USA Inc. (D. Del. 2017)

Docket		Date Filed	2017-02-14
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	6,956,041; 6,965,027; 7,091,208; 7,265,221; 7,301,023; RE41,783
Link to Docket	External link to docket

Details for Pfizer Inc. v. Micro Labs USA Inc. (D. Del. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-02-14	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,965,027 B2; 7,301,023 B2; RE41,783…14 February 2017 1:17-cv-00158-LPS Patent None District Court, D. Delaware	External link to document
2018-06-27	78	Complaint - Amended	four additional patents for Xeljanz® that are not at issue: U.S. Patent Nos. 6,956,041 (expiring December…of United States Patent No. 6,965,027 (the “’027 patent”) and United States Patent No. 7,301,023 (the…expiration date for the ’027 patent as March 25, 2023 and the ’023 patent as May 23, 2022. 24…expiration date of the RE’783 patent to December 8, 2025. The ’027 Patent 25. On November ….” The ’027 patent is duly and legally assigned to Pfizer Inc. A copy of the ’027 patent is attached	External link to document
2018-10-25	97		.S. Reissue Patent No. RE41 ,783 (the '" 783 patent"). The ' 783 patent generally relates…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification …or "Plaintiffs") have brought several patent infringement suits pursuant to the Hatch- Waxman…therapy as immunosuppressive agents. (See ' 783 patent at 1:13-17) Plaintiffs' relevant brand name	External link to document